-
1
-
-
33646548277
-
Treatment of acute graft-versus-host disease with prednisolone: Significant survival advantage for day +5 responders and no advantage for nonresponders receiving anti-thymocyte globulin
-
DOI 10.1182/blood-2005-12-4851
-
Van Lint MT, Milone G, Leotta S, Uderzo C, Scime R, Dallorso S et al. Treatment of acute graft-versus-host disease with prednisolone: significant survival advantage for day +5 responders and no advantage for nonresponders receiving anti-thymocyte globulin. Blood 2006; 107: 4177-4181. (Pubitemid 43726830)
-
(2006)
Blood
, vol.107
, Issue.10
, pp. 4177-4181
-
-
Van Lint, M.T.1
Milone, G.2
Leotta, S.3
Uderzo, C.4
Scime, R.5
Dallorso, S.6
Locasciulli, A.7
Guidi, S.8
Mordini, N.9
Sica, S.10
Cudillo, L.11
Fagioli, F.12
Selleri, C.13
Bruno, B.14
Arcese, W.15
Bacigalupo, A.16
-
2
-
-
41349118744
-
Etanercept plus methylprednisolone as initial therapy for acute graft-versus-host disease
-
DOI 10.1182/blood-2007-09-112987
-
Levine JE, Paczesny S, Mineishi S, Braun T, Choi SW, Hutchinson RJ et al. Etanercept plus methylprednisolone as initial therapy for acute graft-versus-host disease. Blood 2008; 111: 2470-2475. (Pubitemid 351451462)
-
(2008)
Blood
, vol.111
, Issue.4
, pp. 2470-2475
-
-
Levine, J.E.1
Paczesny, S.2
Mineishi, S.3
Braun, T.4
Choi, S.W.5
Hutchinson, R.J.6
Jones, D.7
Khaled, Y.8
Kitko, C.L.9
Bickley, D.10
Krijanovski, O.11
Reddy, P.12
Yanik, G.13
Ferrara, J.L.M.14
-
3
-
-
0036210985
-
Poor outcome in steroid-refractory graft-versus-host disease with antithymocyte globulin treatment
-
Arai S, Margolis J, Zahurak M, Anders V, Vogelsang GB. Poor outcome in steroid-refractory graft-versus-host disease with antithymocyte globulin treatment. Biol Blood Marrow Transplant 2002; 8: 155-160. (Pubitemid 34285074)
-
(2002)
Biology of Blood and Marrow Transplantation
, vol.8
, Issue.3
, pp. 155-160
-
-
Arai, S.1
Margolis, J.2
Zahurak, M.3
Anders, V.4
Vogelsang, G.B.5
-
4
-
-
34247867901
-
Immunobiology of allogeneic hematopoietic stem cell transplantation
-
DOI 10.1146/annurev.immunol.25.022106.141606
-
Welniak LA, Blazar BR, Murphy WJ. Immunobiology of allogeneic hematopoietic stem cell transplantation. Annu Rev Immunol 2007; 25: 139-170. (Pubitemid 46697905)
-
(2007)
Annual Review of Immunology
, vol.25
, pp. 139-170
-
-
Welniak, L.A.1
Blazar, B.R.2
Murphy, W.J.3
-
5
-
-
58149384550
-
Graft-versus-leukemia effects of transplantation and donor lymphocytes
-
Kolb HJ. Graft-versus-leukemia effects of transplantation and donor lymphocytes. Blood 2008; 112: 4371-4383.
-
(2008)
Blood
, vol.112
, pp. 4371-4383
-
-
Kolb, H.J.1
-
7
-
-
0030861750
-
Total body irradiation and acute graft-versus-host disease: The role of gastrointestinal damage and inflammatory cytokines
-
Hill GR, Crawford JM, Cooke KR, Brinson YS, Pan L, Ferrara JL. Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines. Blood 1997; 90: 3204-3213. (Pubitemid 27444217)
-
(1997)
Blood
, vol.90
, Issue.8
, pp. 3204-3213
-
-
Hill, G.R.1
Crawford, J.M.2
Cooke, K.R.3
Brinson, Y.S.4
Pan, L.5
Ferrara, J.L.M.6
-
8
-
-
0034103630
-
Th1 and Th2 mediate acute graft-versus-host disease, each with distinct end-organ targets
-
Nikolic B, Lee S, Bronson RT, Grusby MJ, Sykes M. Th1 and Th2 mediate acute graft-versus-host disease, each with distinct end-organ target. J Clin Invest 2000; 105: 1289-1298. (Pubitemid 30266082)
-
(2000)
Journal of Clinical Investigation
, vol.105
, Issue.9
, pp. 1289-1298
-
-
Nikolic, B.1
Lee, S.2
Bronson, R.T.3
Grusby, M.J.4
Sykes, M.5
-
9
-
-
39649095444
-
Serum cytokeratin-18 fragments as quantitative markers of epithelial apoptosis in liver and intestinal graft-versus-host disease
-
DOI 10.1182/blood-2006-10-049817
-
Luft T, Conzelmann M, Benner A, Rieger M, Hess M, Strohhaecker U et al. Serum cytokeratin-18 fragments as quantitative markers of epithelial apoptosis in liver and intestinal graft-versus-host disease. Blood 2007; 110: 4535-4542. (Pubitemid 351377821)
-
(2007)
Blood
, vol.110
, Issue.13
, pp. 4535-4542
-
-
Luft, T.1
Conzelmann, M.2
Benner, A.3
Rieger, M.4
Hess, M.5
Strohhaecker, U.6
Gorner, M.7
Hegenbart, U.8
Ho, A.D.9
Dreger, P.10
-
10
-
-
71849118213
-
A new approach to the blocking of alloreactive T-cell mediated graft-versus-host disease by in vivo administration of anti-CXCR3 neutralizing antibody
-
He S, Cao Q, Qiu Y, Mi J, Zhang JZ, Jin M et al. A new approach to the blocking of alloreactive T-cell mediated graft-versus-host disease by in vivo administration of anti-CXCR3 neutralizing antibody. J Immunol 2008; 181: 7581-7592.
-
(2008)
J Immunol
, vol.181
, pp. 7581-7592
-
-
He, S.1
Cao, Q.2
Qiu, Y.3
Mi, J.4
Zhang, J.Z.5
Jin, M.6
-
11
-
-
0037713989
-
Pentostatin (2prime prime or minute-deoxycofor-mycin): Clinical pharmacology, role in cancer chemotherapy, and future prospects
-
Spiers AS. Pentostatin (2prime prime or minute-deoxycofor-mycin): clinical pharmacology, role in cancer chemotherapy, and future prospects. Am J Ther 1995; 2: 196-216.
-
(1995)
Am J Ther
, vol.2
, pp. 196-216
-
-
Spiers, A.S.1
-
12
-
-
79953719569
-
SCID: The role of adenosine deaminase deficiency
-
Resta R, Thompson LF. SCID: the role of adenosine deaminase deficiency. Immunol Today 1997; 19: 533-534.
-
(1997)
Immunol Today
, vol.19
, pp. 533-534
-
-
Resta, R.1
Thompson, L.F.2
-
13
-
-
12344281073
-
New insights into adenosine-receptor-mediated immunosuppression and the role of adenosine in causing the immunodeficiency associated with adenosine deaminase defi-ciency
-
Hershfield MS. New insights into adenosine-receptor-mediated immunosuppression and the role of adenosine in causing the immunodeficiency associated with adenosine deaminase defi-ciency. Eur J Immunol 2005; 35: 31-41.
-
(2005)
Eur J Immunol
, vol.35
, pp. 31-41
-
-
Hershfield, M.S.1
-
15
-
-
0027417515
-
Pentostatin in prolymphocytic leukemia: Phase II trial of the European Organization for Research and Treatment of Cancer Leukemia Cooperative Study Group
-
Dohner H, Ho AD, Thaler J, Stryckmans P, Sonneveld P, de Witte T et al. Pentostatin in prolymphocytic leukemia: phase II trial of the European Organization for Research and Treatment of Cancer Leukemia Cooperative Study Group. J Natl Cancer Inst 1993; 85: 658-662. (Pubitemid 23120512)
-
(1993)
Journal of the National Cancer Institute
, vol.85
, Issue.8
, pp. 658-662
-
-
Dohner, H.1
Ho, A.D.2
Thaler, J.3
Stryckmans, P.4
Sonneveld, P.5
De Witte, T.6
Lechner, K.7
Lauria, F.8
Bodewadt-Radzun, S.9
Suciu, S.10
Solbu, G.11
Witt, B.12
Hunstein, W.13
Zittoun, R.14
-
16
-
-
0033371463
-
Pentostatin in T-cell malignancies - A phase II trial of the EORTC
-
DOI 10.1023/A:1008377724139
-
Ho AD, Suciu S, Stryckmans P, De Cataldo F, Willemze R, Thaler J et al. Pentostatin in T-cell malignancies\a phase II trial of the EORTC. Leukemia Cooperative Group. Ann Oncol 1999; 10: 1493-1498. (Pubitemid 30017061)
-
(1999)
Annals of Oncology
, vol.10
, Issue.12
, pp. 1493-1498
-
-
Ho, A.D.1
Suciu, S.2
Stryckmans, P.3
De Cataldo, F.4
Willemze, R.5
Thaler, J.6
Peetermans, M.7
Dohner, H.8
Solbu, G.9
Dardenne, M.10
Zittoun, R.11
-
17
-
-
0023006839
-
Prevention of graft-versus-host-disease in allogeneic bone marrow transplantation by pretreatment with 2'-deoxycoformycin
-
Epstein J, Bealmear PM, Kennedy DW, Herrmann MJ, Islam A, Wiedl SC. Prevention of graft-versus-host disease in allogeneic bone marrow transplantation by pretreatment with 2'-deoxycoformycin. Exp Hematol 1986; 14: 845-849. (Pubitemid 17180037)
-
(1986)
Experimental Hematology
, vol.14
, Issue.9
, pp. 845-849
-
-
Epstein, J.1
Bealmear, P.M.2
Kennedy, D.W.3
-
18
-
-
21044441501
-
Pentostatin in steroid-refractory acute graft-versus-host disease
-
DOI 10.1200/JCO.2005.06.130
-
Bolanos-Meade J, Jacobsohn DA, Margolis J, Ogden A, Wientjes G, Byrd JC et al. Pentostatin in steroid-refractory acute graft-versus-host disease. J Clin Oncol 2005; 23: 2661-2668. (Pubitemid 46179455)
-
(2005)
Journal of Clinical Oncology
, vol.23
, Issue.12
, pp. 2661-2668
-
-
Bolanos-Meade, J.1
Jacobsohn, D.A.2
Margolis, J.3
Ogden, A.4
Wientjes, M.G.5
Byrd, J.C.6
Lucas, D.M.7
Anders, V.8
Phelps, M.9
Grever, M.R.10
Vogelsang, G.B.11
-
19
-
-
79953701839
-
Long-Term follow up of a phase II study of pentostatin in patients with steroid refractory acute intestinal graft-versus-host dis-ease
-
abstract 773
-
Klein S, Mousset S, Bug G, Wassmann B, Martin H. Long-Term follow up of a phase II study of pentostatin in patients with steroid refractory acute intestinal graft-versus-host dis-ease. Bone Marrow Transplant 2008; 41(Suppl 1): S222 (abstract 773).
-
(2008)
Bone Marrow Transplant
, vol.41
, Issue.SUPPL. 1
-
-
Klein, S.1
Mousset, S.2
Bug, G.3
Wassmann, B.4
Martin, H.5
-
20
-
-
0029029246
-
Consensus conference on acute GVHD grading
-
Przepiorka JD, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J et al. Consensus conference on acute GVHD grading. Bone Marrow Transplant 1995; 15: 825-828.
-
(1995)
Bone Marrow Transplant
, vol.15
, pp. 825-828
-
-
Przepiorka, J.D.1
Weisdorf, D.2
Martin, P.3
Klingemann, H.G.4
Beatty, P.5
Hows, J.6
-
21
-
-
70149119758
-
Evaluation of NIH consensus criteria for classification of late acute and chronic GVHD
-
Vigorito AC, Campregher PV, Storer BE, Carpenter PA, Moravec CK, Kiem HP et al. Evaluation of NIH consensus criteria for classification of late acute and chronic GVHD. Blood 2009; 114: 702-708.
-
(2009)
Blood
, vol.114
, pp. 702-708
-
-
Vigorito, A.C.1
Campregher, P.V.2
Storer, B.E.3
Carpenter, P.A.4
Moravec, C.K.5
Kiem, H.P.6
-
22
-
-
67349104999
-
Endpoints for clinical trials testing treatment of acute graft-versus-host disease: A joint statement
-
Martin PJ, Bachier CR, Klingemann HG, McCarthy PL, Szabolcs P, Uberti JP et al. Endpoints for clinical trials testing treatment of acute graft-versus-host disease: a joint statement. Biol Blood Marrow Transplant 2009; 15: 777-784.
-
(2009)
Biol Blood Marrow Transplant
, vol.15
, pp. 777-784
-
-
Martin, P.J.1
Bachier, C.R.2
Klingemann, H.G.3
McCarthy, P.L.4
Szabolcs, P.5
Uberti, J.P.6
-
23
-
-
27744586984
-
OKT3 muromonab as second-line and subsequent treatment in recipients of stem cell allografts with steroid-resistant acute graft-versus-host disease
-
DOI 10.1038/sj.bmt.1705132, PII 1705132
-
Knop S, Hebart H, Gscheidle H, Holler E, Kolb HJ, Niederwieser D et al. OKT3 muromonab as second-line and subsequent treatment in recipients of stem cell allografts with steroid-resistant acute graft-versus-host disease. Bone Marrow Transplant 2005; 36: 831-837. (Pubitemid 41613308)
-
(2005)
Bone Marrow Transplantation
, vol.36
, Issue.9
, pp. 831-837
-
-
Knop, S.1
Hebart, H.2
Gscheidle, H.3
Holler, E.4
Kolb, H.-J.5
Niederwieser, D.6
Einsele, H.7
-
24
-
-
34447644425
-
Treatment of steroid-resistant acute GVHD with OKT3 and high-dose steroids results in better disease control and lower incidence of infectious complications when compared to high-dose steroids alone: A randomized multicenter trial by the EBMT Chronic Leukemia Working Party [7]
-
DOI 10.1038/sj.leu.2404731, PII 2404731
-
Knop S, Hebart H, Gratwohl A, Kliem C, Faul C, Holler E et al. Treatment of steroid-resistant acute GVHD with OKT3 and high-dose steroids results in better disease control and lower incidence of infectious complications when compared to high-dose steroids alone: a randomized multicenter trial by the EBMT Chronic Leukemia Working Party. Leukemia 2009; 21: 1830-1833. (Pubitemid 47086777)
-
(2007)
Leukemia
, vol.21
, Issue.8
, pp. 1830-1833
-
-
Knop, S.1
Hebart, H.2
Gratwohl, A.3
Kliem, C.4
Faul, C.5
Holler, E.6
Apperley, J.7
Kolb, H.J.8
Schaefer, A.9
Niederwieser, D.10
Einsele, H.11
-
25
-
-
0033964862
-
Daclizumab, a humanized anti-interleukin-2 receptor alpha chain antibody, for treatment of acute graft-versus-host disease
-
Przepiorka D, Kernan NA, Ippoliti C, Papadopoulos EB, Giralt S, Khouri I et al. Daclizumab, a humanized antiinterleukin-2 receptor alpha chain antibody, for treatment of acute graft-versus-host disease. Blood 2000; 95: 83-89. (Pubitemid 30017229)
-
(2000)
Blood
, vol.95
, Issue.1
, pp. 83-89
-
-
Przepiorka, D.1
Kernan, N.A.2
Ippoliti, C.3
Papadopoulos, E.B.4
Giralt, S.5
Khouri, I.6
Lu, J.-G.7
Gajewski, J.8
Durett, A.9
Cleary, K.10
Champlin, R.11
Andersson, B.S.12
Light, S.13
-
26
-
-
0036947659
-
Basiliximab is well tolerated and effective in the treatment of steroid-refractory acute graft-versus-host disease after allogeneic stem cell transplantation
-
DOI 10.1038/sj.bmt.1703737
-
Massenkeil G, Rackwitz S, Genvresse I, Rosen O, Dorken B, Arnold R. Basiliximab is well tolerated and effective in the treatment of steroid-refractory acute graft-versus-host disease after allogeneic stem cell transplantation. Bone Marrow Transplant 2002; 30: 899-903. (Pubitemid 36097479)
-
(2002)
Bone Marrow Transplantation
, vol.30
, Issue.12
, pp. 899-903
-
-
Massenkeil, G.1
Rackwitz, S.2
Genvresse, I.3
Rosen, O.4
Dorken, B.5
Arnold, R.6
-
27
-
-
3242756749
-
Tumor necrosis factor-α blockade for the treatment of acute GVHD
-
DOI 10.1182/blood-2003-12-4241
-
Couriel D, Saliba R, Hicks K, Ippoliti C, de Lima M, Hosing C et al. Tumor necrosis factor-alpha blockade for the treatment of acute GVHD. Blood 2004; 104: 649-654. (Pubitemid 38970556)
-
(2004)
Blood
, vol.104
, Issue.3
, pp. 649-654
-
-
Couriel, D.1
Saliba, R.2
Hicks, K.3
Ippoliti, C.4
De Lima, M.5
Hosing, C.6
Khouri, I.7
Andersson, B.8
Gajewski, J.9
Donato, M.10
Anderlini, P.11
Kontoyiannis, D.P.12
Cohen, A.13
Martin, T.14
Giralt, S.15
Champlin, R.16
-
28
-
-
67849133675
-
Infliximab for managing steroid-refractory acute graft-versus-host disease
-
Pidala J, Kim J, Field T, McBride A, Kharfan-Dabaja M, Perkins J et al. Infliximab for managing steroid-refractory acute graft-versus-host disease. Biol Blood Marrow Transplant 2009; 15: 1116-1121.
-
(2009)
Biol Blood Marrow Transplant
, vol.15
, pp. 1116-1121
-
-
Pidala, J.1
Kim, J.2
Field, T.3
McBride, A.4
Kharfan-Dabaja, M.5
Perkins, J.6
-
29
-
-
56349140988
-
Extracoporeal photopheresis for the treatment of steroid refractory acute GVHD
-
Perfetti P, Carlier P, Strada P, Gualandi F, Occhini D, Van Lint MT et al. Extracoporeal photopheresis for the treatment of steroid refractory acute GVHD. Bone Marrow Transplant 2008; 42: 609-617.
-
(2008)
Bone Marrow Transplant
, vol.42
, pp. 609-617
-
-
Perfetti, P.1
Carlier, P.2
Strada, P.3
Gualandi, F.4
Occhini, D.5
Van Lint, M.T.6
-
30
-
-
33645406536
-
The effect of intensified extracorporeal photochemotherapy on long-term survival in patients with severe acute graft-versus-host disease
-
Greinix HT, Knobler RM, Worel N, Schneider B, Schneeberger A, Hoecker P et al. The effect of intensified extracorporeal photochemotherapy on long-term survival in patients with severe acute graft-versus-host disease. Haemato-logica 2006; 91: 405-408.
-
(2006)
Haemato-logica
, vol.91
, pp. 405-408
-
-
Greinix, H.T.1
Knobler, R.M.2
Worel, N.3
Schneider, B.4
Schneeberger, A.5
Hoecker, P.6
-
31
-
-
43049103438
-
Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: A phase II study
-
DOI 10.1016/S0140-6736(08)60690-X, PII S014067360860690X
-
Le Blanc K, Frassoni F, Ball L, Locatelli F, Roelofs H, Lewis I et al. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 2008; 371: 1579-1586. (Pubitemid 351626841)
-
(2008)
The Lancet
, vol.371
, Issue.9624
, pp. 1579-1586
-
-
Le Blanc, K.1
Frassoni, F.2
Ball, L.3
Locatelli, F.4
Roelofs, H.5
Lewis, I.6
Lanino, E.7
Sundberg, B.8
Bernardo, M.E.9
Remberger, M.10
Dini, G.11
Egeler, R.M.12
Bacigalupo, A.13
Fibbe, W.14
Ringden, O.15
-
32
-
-
60349129494
-
Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing medium
-
Von Bonin M, Stolzel F, Goedecke A, Richter K, Wuschek N, Holig K et al. Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing medium. Bone Marrow Transplant 2009; 43: 245-251.
-
(2009)
Bone Marrow Transplant
, vol.43
, pp. 245-251
-
-
Von Bonin, M.1
Stolzel, F.2
Goedecke, A.3
Richter, K.4
Wuschek, N.5
Holig, K.6
-
33
-
-
77955518690
-
Prochymal improves response rates in patients with steroid-refractory acute graft versus host disease (SR-GVHD) involving the liver and gut: Results of a randomized, placebo-controlled, multicenter phase III trial in GVHD
-
Martin PJ, Uberti JP, Soiffer RJ, Klingemann H, Waller EK, Daly AS et al. Prochymal improves response rates in patients with steroid-refractory acute graft versus host disease (SR-GVHD) involving the liver and gut: results of a randomized, placebo-controlled, multicenter phase III trial in GVHD. Biol Blood Marrow Transplant 2010; 16(Suppl. 2): 169-170.
-
(2010)
Biol Blood Marrow Transplant
, vol.16
, Issue.SUPPL. 2
, pp. 169-170
-
-
Martin, P.J.1
Uberti, J.P.2
Soiffer, R.J.3
Klingemann, H.4
Waller, E.K.5
Daly, A.S.6
-
34
-
-
58849144772
-
A biomarker panel for acute graft-versus-host disease
-
Paczesny S, Krijanovski OI, Braun TM, Choi SW, Clouthier SG, Kuick R et al. A biomarker panel for acute graft-versus-host disease. Blood 2009; 113: 273-278.
-
(2009)
Blood
, vol.113
, pp. 273-278
-
-
Paczesny, S.1
Krijanovski, O.I.2
Braun, T.M.3
Choi, S.W.4
Clouthier, S.G.5
Kuick, R.6
|